Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

The German Psoriasis Registry PsoBest was conducted in 2008 in order to investigate the long-term outcomes and safety of systemic treatments for moderate-to-severe psoriasis. Safety analysis of antipsoriatic drugs with special focus on serious adverse events (SAE) for infections, malignancies and ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Reich, K., Mrowietz, U., Radtke, M. A., Thaci, D., Rustenbach, S. J., Spehr, C., Augustin, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643107/
https://www.ncbi.nlm.nih.gov/pubmed/26358263
http://dx.doi.org/10.1007/s00403-015-1593-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643107/
https://www.ncbi.nlm.nih.gov/pubmed/26358263
http://dx.doi.org/10.1007/s00403-015-1593-8

Ejemplares similares